MODERN CONCEPTS OF SYSTEMIC ARTERIAL HYPERTENSION AS COMPLICATION OF BRONCHOPULMONARY DYSPLASIA

Cover Page

Cite item

Full Text

Abstract

Arterial hypertension (AH) is highlighted as a complication of bronchopulmonary dys-plasia (BPD) in children. The review provides information on the incidence, pathophysiology, diagnosis and treatment of AH in children with BPD. After analyzing the studies, were identified risk factors for hypertension in children with BPD, the role of endothelial dysfunction in raising systemic blood pressure, analyzed therapy and consequences of AH in children with BPD.

About the authors

D Yu Ovsyannikov

RUDN University

Author for correspondence.
Email: mdovsyannikov@yahoo.com

доктор медицинских наук, зав. каф. педиатрии Российского университета дружбы народов

Москва. 117198, Москва, ул. Миклухо-Маклая, 8

A D Strutynskaya

Pirogov Russian National Research Medical University

Email: konovalov_oe@rudn.university

M G Kantemirova

RUDN University

Email: konovalov_oe@rudn.university
Москва. 117198, Москва, ул. Миклухо-Маклая, 8

M A Karnaushkina

First Moscow State Medical University named after I.M. Sechenov, Moscow, RF

Email: konovalov_oe@rudn.university

References

  1. Neal W. A. & Adelman R. D. Neonatal hypertension. Pediatr Clin North Am 1978. V. 25. P. 99—110.
  2. Flynn J. T. Neonatal hypertension: diagnosis and management. Pediatr Nephrol. 2000. V. 14. P. 332—341.
  3. De Jong F., Monuteaux M. C., Van Elburg R. M., Gillman M. W. & Belfort M. B. Systematic review and meta-analysis of preterm birth and later systolic blood pressure. Hypertension. 2012. V. 59. N 2. Р. 226—234.
  4. Ovsyannikov D. Yu., Antonov A. G., Ionov O. V., Ryndin A. Yu., Levadnaya A. V., & Iva¬nov D. O. Draft protocol on diagnosis, prevention and treatment of bronchopulmonary dys¬plasia. Neona-tology: news, opinions, training. 2014. V. 1. N 3. P. 161—175.
  5. U.S. Department of Health and Human Services. The fourth report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. Pediatrics. 2004. V. 114. N 2. Р. 555—576.
  6. URL: www.adhb.govt.nz/newborn/Guidelines/Cardiac/Hypertension.htm (date of the application).
  7. Abman S. H., Warady B. A., Lum G. M. & Koops B. L. Systemic hypertension in infants with bron-chopulmonary dysplasia. J Pediatr 1984. V. 104. P. 928—931.
  8. Alagappan A. & Malloy M. H. Systemic hypertension in very low birth weight infants with bron-chopulmonary dysplasia: incidence and risk factors. Am J Perinatol. 1998. V. 15. P. 3—8.
  9. Sehgal A., Malikiwi A., Paul E., Tan K. & Menahem S. Systemic arterial stiffness in infants with bronchopulmonary dysplasia: potential cause of systemic hypertension. J Perinatol. 2016. V. 1. P. 1—6.
  10. Anderson A. H., Warady B. A., Daily D. K., Johnson J. A. & Thomas M. K. Systemic hyperten-sion in infants with severe bronchopulmonary dysplasia: associated clinical factors. Am J Perinatol 1993. V. 10. P. 190—193.
  11. Jobe A. H., Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001. V. 163. N 7. Р. 1723—1729.
  12. Neptune E. R. Chronic obstructive pulmonary disease and bronchopulmonary dysplasia: Common mechanisms but distinct manifestations? Pediatric Allergy, Immunology, and Pulmonology. 2011. V. 24. N 2. Р. 119—125.
  13. Clarenbach C. F., Senn O., Sievi N. A., Arnoldus G. C., Van Gestel G. R., Rossi G. A., Puhan M. A., Thurnheer R., Russi W. & Kohler M. Determinants of endothelial function in patients with COPD. Eur. Respir J. 2013. V. 42. P. 1194—1204.
  14. Sinden N. J. Systemic inflammation and comorbidity in COPD: a result of ‘overspill’ of inflammatory mediators from the lungs? Review of the evidence. Thorax. 2010. V. 65. P. 930—936.
  15. Romme Е., McAllister D. A., Murchison J. T., Van Beek E. J. R., Petrides G. S., Price C. O. S., Rut-ten E. P. A., Smeenk F., Wouters E. & MacNee W. Associations between COPD related manifestations: a cross-sectional study. Respiratory Research. 2013. V. 14. P. 129—136.
  16. Boytsova E. V., Zapevalova E. Yu. & Ovsyannikov D. Yu. Respiratory, neurological and func¬tional consequences of bronchopulmonary dysplasia in children and adults. Neonatology: news, opinions, training. 2014. V. 1. P. 71—79.
  17. Ovsyannikov D. Yu., Zaitseva N. O., Shokin A. A. & Degtyareva E. A. Complications of bron¬chopulmonary dysplasia: pulmonary hypertension and pulmonary heart. Neonatology: news, opin-ions, training. 2014. V. 2. Р. 38—48.
  18. Ovsyannikov D. Yu., Degtyareva E. A., Zaitseva N. O. & Shokin A. A. Pulmonary hypertension and pulmonary heart in children with bronchopulmonary dysplasia: risk factors, diagnosis, treatment and prevention options. Pediatrics. 2013. V. 92. N 5. Р. 32—39.
  19. Guyton A. K. & Hall D. E. Medical physiology. Trans. from the english; V.I. Kobrin Eds. Mos-cow: The Logosphere, 2008: 1296.
  20. Dionne J. M., Abitbol C. L. & Flynn J. T. Hypertension in infancy: diagnosis, management and outcome. Pediatric nephrology. 2010 V. 27. N 1. P. 17—32.
  21. Wells T. G., Bunchman T. E. & Kearns G. L. Treatment of neonatal hypertension with enalaprilat. J Pediatr. 1990. V. 117. P. 664—667.
  22. Mason T., Polak M. J., Pyles L., Mullett M. & Swanke C. Treatment of neonatal renovascular hyper-tension with intravenous enalapril. Am J Perinatol. 1992. V. 9. P. 254—257.

Copyright (c) 2017 Ovsyannikov D.Y., Strutynskaya A.D., Kantemirova M.G., Karnaushkina M.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies